Dacron-covered Stent-Grafts in Transjugular Intrahepatic Portosystemic Shunts: Initial Experience
Abstract
PURPOSE: To retrospectively review the authors' experience with use of a Dacron-covered stent-graft in transjugular intrahepatic postosystemic shunts (TIPS).
MATERIALS AND METHODS: The need for internal review board approval was waived. Informed consent was obtained from all patients. The study was compliant with the Health Insurance Portability and Accountability Act. A retrospective analysis was performed of 16 patients who received a Dacron-covered stent-graft during revision or de novo creation of TIPS. There were 13 men and three women aged 44–80 years (mean age, 61 years). Primary unassisted and assisted patency rates and secondary patency rates were estimated. The primary unassisted patency of patients who underwent de novo placement of stent-grafts (n = 10) was compared with that of patients with stent-grafts placed during shunt revision (n = 6); in all patients, stent-grafts were placed within stents. Primary unassisted patency was also compared between patients in whom the covered stent was confined to the parenchymal tract (n = 7) and those in whom the stent extended 1 cm or more into the portal vein (n = 9). Patency was estimated with the Kaplan-Meier method, and group comparisons were performed with the log-rank test.
RESULTS: Primary unassisted patency rates following stent-graft placement at 4, 12, and 24 months (± standard error) were 64% ± 14, 54% ± 15, and 40% ± 16, respectively. The rates for primary assisted patency were 78% ± 12, 67% ± 14, and 67% ± 14 and those for secondary patency were 91% ± 9, 81% ± 12, and 54% ± 23. At 12 months, primary unassisted patency with de novo stent-graft placement was 90% ± 9, whereas that with stent-grafts placed during TIPS revision was 17% ± 15 (P = .005). At 12 months, the primary unassisted patency in patients with stent-grafts confined to the parenchymal tract was 75% ± 22, and that of patients with stent-grafts extending at least 1 cm into the portal vein was 40% ± 17 (P = .21).
CONCLUSION: In this small series, satisfactory long-term patency was observed among patients in whom Dacron-covered stent-grafts were placed during revision or de novo creation of TIPS. More favorable outcomes were observed when the stent-graft was placed during de novo TIPS creation and when the device was confined to the parenchymal tract.
© RSNA, 2005
References
- 1
, Stronell RD, Gildiner M, et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol 1983; 140:709–714.Colapinto RF - 2
, Noeldge G, Palmaz JC, et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 1990; 174:1027–1030.Richter GM - 3
, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701–1707.Rossle M - 4
, Genning C, Reddy KR, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124:634–641.Sanyal AJ - 5
, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest 1994; 106:1293–1295.Haskal ZJ - 6
, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13:529–534.Siegerstetter V - 7
, Sellinger M, Haag K, et al. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993; 18:217–225.Ochs A - 8
, Peck-Radosavljevic M, Schoder M, et al. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol 2002; 13:193–199.Cejna M - 9
, Textor J, Perz J, et al. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47:288–295.Brensing KA - 10
, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:1143–1151.LaBerge JM - 11
, Timmermans HA, Uchida BT, et al. Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study. J Vasc Interv Radiol 1997; 8:539–548.Saxon RR - 12
. Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts. Radiology 1999; 213:759–766.Haskal ZJ - 13
, Rousseau H, Vinel JP, Ducoin H, Hassissene S, Joffre F. High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent. J Vasc Interv Radiol 1999; 10:183–188.Otal P - 14
, Brennecke LH. Transjugular intrahepatic portosystemic shunts formed with polyethylene terephthalate–covered stents: experimental evaluation in pigs. Radiology 1999; 213:853–859.Haskal ZJ - 15
, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464–470.Kamath PS - 16
, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187:413–420.LaBerge JM - 17
, Rees CR, Ring EJ, Saxon R, Sacks D. Reporting standards for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003; 14(9 Pt 2):S419–S426.Haskal ZJ - 18
, Darcy MD, Middleton WD, Sterling KM, Teefey SA, Pilgram TK. Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction. AJR Am J Roentgenol 1997; 168:467–472.Kanterman RY - 19
, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003; 14(9 Pt 2):S265–S270.Haskal ZJ - 20
, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1993; 4:779–786.LaBerge JM - 21
, Contos MJ, Yager D, Zhu YN, Willey A, Graham MF. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. Hepatology 1998; 28:22–32.Sanyal AJ - 22
, Mirshahi F. Endothelial cells lining transjugular intrahepatic portasystemic shunts originate in hepatic sinusoids: implications for pseudointimal hyperplasia. Hepatology 1999; 29:710–718.Sanyal AJ - 23
, Saxon RR, Kubota Y, et al. Transjugular intrahepatic portosystemic shunt with silicone-covered Wallstents: results in a swine model. Radiology 1997; 205:181–184.Tanihata H - 24
, Brennecke LJ. Porous and nonporous polycarbonate urethane stent-grafts for TIPS formation: biologic responses. J Vasc Interv Radiol 1999; 10:1255–1263.Haskal ZJ - 25
, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine. Radiology 1995; 196:341–347.Nishimine K - 26
, Saxon RR, Bloch RD, et al. Stent-grafts for de novo TIPS: technique and early results. J Vasc Interv Radiol 1999; 10:1371–1378.Andrews RT - 27
, Peck-Radosavljevic M, Thurnher SA, Hittmair K, Schoder M, Lammer J. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis. Radiology 2001; 221:437–446.Cejna M - 28
, Peck-Radosavljevic M, Thurnher S, et al. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol 2002; 25:365–372.Cejna M - 29
, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stent-grafts versus bare stents. Hepatology 2003; 38:1043–1050.Angermayr B - 30
, Karnel F, Georgieva B, et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 2004; 15:239–248.Hausegger KA - 31
, Salvatori FM, Fanelli F, et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004; 231:820–830.Rossi P - 32
, Koops A, Habermann CR, Weiss F, Adam G, Krupski G. Bile resistance of coated transjugular intrahepatic portosystemic shunt stents in a flow-model. Invest Radiol 2004; 39:717–722.Wittkugel O - 33
, Agarwal R, Haskal ZJ, Stavropoulos SW. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2004; 15:147–152.Clark TW - 34
, Weintraub JL, Susman J. Recurrent TIPS thrombosis after polyethylene stent-graft use and salvage with polytetrafluoroethylene stent-grafts. J Vasc Interv Radiol 2002; 13:1255–1259.Haskal ZJ